New Haven, CT’s Trevi Therapeutics banked another $11 million in venture cash, bringing its B round to $26 million and giving it the cash it needs to complete a pivotal trial for its top prospect.

…read more

Source: Trevi wraps up a $26M round to fund its anti-itching drug


0 No comments